Marshall Wace North America’s Core Laboratories CLB Stock Holding History

Marshall Wace North America’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.74M	Buy	+134,680	New	+$4.1M	0.02%	576
2019 Q3	–	Sell	-133,005	Closed	-$6.95M	–	1333
2019 Q2	$6.95M	Buy	133,005 +132,102	+14,629%	+$7.75M	0.04%	293
2019 Q1	$62K	Sell	903 -6,383	-88%	-$428K	﹤0.01%	1217
2018 Q4	$434K	Buy	+7,286	New	+$629K	﹤0.01%	811
2018 Q2	–	Sell	-110,779	Closed	-$12M	–	1422
2018 Q1	$12M	Buy	110,779 +67,445	+156%	+$7.46M	0.06%	357
2017 Q4	$4.75M	Buy	+43,334	New	+$4.33M	0.03%	593
2017 Q2	–	Sell	-68,380	Closed	-$7.93M	–	1308
2017 Q1	$7.93M	Buy	+68,380	New	+$7.95M	0.06%	310

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Marshall Wace North America's CLB Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Core Laboratories (CLB) in Q3 2021: 134,680 shares worth $3.74M. The stake represents 0.02% of the portfolio and ranks #576 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in CLB as recently as Q2 2019.

Marshall Wace North America first reported a position in CLB in Q1 2017 and has held it in 7 quarters since. The position peaked at $12M in Q1 2018. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

Marshall Wace North America held 134,680 shares of Core Laboratories worth $3.74M as of Q3 2021.
Core Laboratories was a new Marshall Wace North America position in Q3 2021.
Core Laboratories made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #576 holding.
Marshall Wace North America first reported a position in Core Laboratories in Q1 2017 and has held it in 7 quarters since.
Marshall Wace North America's Core Laboratories position peaked at $12M in Q1 2018.
198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.